ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
03 Apr 2023

Acarix accelerates US commercialization into 30 additional states

Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announced a strategic sales partnership with CompleMed, LLC, a nat...
Continue reading
author-avatar acarix
Press
August 6, 2024
03 Apr 2023

Acarix accelererar kommersialiseringen i USA till ytterligare 30 delstater

Acarix, ledare inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag ett nytt strategiskt samarbete med CompleMed, en landstäckan...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Mar 2023

Studie publicerad i Heart stärker det diagnostiska värdet av Acarix CADScor System

Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, tillkännagav idag publiceringen av en ny studie i den ansedda vetenskapli...
Continue reading
author-avatar acarix
Press
August 6, 2024
06 Mar 2023

Acarix presents at Redeye: Commercialization Seminar

On March 7 at 10.30 CET Helen Ljungdahl Round, CEO of Acarix, presents the latest developments in the company at Redeye. The presentati...
Continue reading
author-avatar acarix
Press
August 6, 2024
06 Mar 2023

Acarix presenterar på Redeye, Seminarium om kommersialisering

Den 7 mars kl 10.30 kommer Helen Ljungdahl Round, VD för Acarix, att presentera den senaste utvecklingen inom företaget. Presentationen...
Continue reading
author-avatar acarix
Press
August 6, 2024
03 Mar 2023

Acarix to showcase at the 2023 ACC congress

Acarix, a leader in acoustic and AI-based cardiac diagnostics, will demonstrate the value of its CADScor System during the American Col...
Continue reading
author-avatar acarix
Press
August 6, 2024
03 Mar 2023

Acarix presenterar på 2023 års ACC-kongress

Acarix, en ledare inom akustisk- och AI-baserad hjärtdiagnostik, kommer att visa värdet av CADScor System under American College of Car...
Continue reading
author-avatar acarix
Press
August 6, 2024
21 Feb 2023

Acarix receives breakthrough order from US Veterans Health Administration

Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the first order from the US Veterans Health Administrati...
Continue reading
author-avatar acarix
Press
August 6, 2024
21 Feb 2023

Acarix erhåller genombrottsorder från US Veterans Health Administration

Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, bekräftar idag att bolaget erhållit den första ordern från US Veterans He...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Feb 2023

ACARIX strengthens US Commercial Team

Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the appointment of two additional members of the Acarix ...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Feb 2023

ACARIX förstärker USA:s kommersiella team

Acarix, en ledare inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag anställningen av två nya medlemmar till Acarix kommersiel...
Continue reading
author-avatar acarix
Press
August 6, 2024
13 Feb 2023

Inbjudan till presentation av Acarix delårsrapport för fjärde kvartalet

Acarix publicerar sin rapport för fjärde kvartalet torsdagen den 16 februari 2023 kl 08.00. En direktsänd websändning kommer att hållas...
Continue reading
  • «
  • ‹
  • 7
  • 8
  • 9
  • 10
  • 11
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.